Jw Asset Management, LLC Eli Lilly & CO Transaction History

Jw Asset Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$724.87 - $909.04 $3.62 Million - $4.55 Million	-5,000 Reduced 37.04%	8,500 $7.7 Million
Q1 2024 May 07, 2024	SELL	$592.2 - $792.28 $7.99 Million - $10.7 Million	-13,500 Reduced 50.0%	13,500 $10.5 Million
Q1 2023 May 05, 2023	BUY	$310.63 - $364.82 $8.39 Million - $9.85 Million	27,000 New	27,000 $9.27 Million

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $743B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Jw Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Jw Asset Management, LLC with notifications on news.